Evidence map›Paper›PMID 32027648›Full record

ArticlePLoS neglected tropical diseases2020

The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.

Moses N Katabarwa, Isam M A Zarroug, Nebiyu Negussu, Nabil M Aziz, Zerihun Tadesse, Wigdan A Elmubark, Zainab Shumo, Kadu Meribo, Hashim Kamal, Aderajew Mohammed and 18 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  19. Article
  20. Elimination ofThe American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 9 institutions in 4 countries.

Moses N KatabarwaHealth Programs, The Carter Center, Atlanta, Georgia, United States of America.ORCID 0000-0003-0416-6393
Isam M A ZarrougFederal Ministry of Health, Khartoum, Sudan.
Nebiyu NegussuFederal Ministry of Health, Addis Ababa, Ethiopia.
Nabil M AzizThe Carter Center, Khartoum, Sudan.
Zerihun TadesseThe Carter Center, Addis Ababa, Ethiopia.
Wigdan A ElmubarkFederal Ministry of Health, Khartoum, Sudan.
Zainab ShumoFederal Ministry of Health, Khartoum, Sudan.
Kadu MeriboFederal Ministry of Health, Addis Ababa, Ethiopia.
Hashim KamalFederal Ministry of Health, Khartoum, Sudan.
Aderajew MohammedThe Carter Center, Addis Ababa, Ethiopia.
Yewondwossen BitewThe Carter Center, Addis Ababa, Ethiopia.
Tewodros SeidThe Carter Center, Addis Ababa, Ethiopia.ORCID 0000-0003-2564-1587
Firdaweke BekeleThe Carter Center, Addis Ababa, Ethiopia.
Abebual YilakThe Carter Center, Addis Ababa, Ethiopia.ORCID 0000-0001-8768-7199
Tekola EndeshawThe Carter Center, Addis Ababa, Ethiopia.
Mohammed HassenThe Carter Center, Addis Ababa, Ethiopia.
Abate TillahunThe Carter Center, Addis Ababa, Ethiopia.
Fikresilasie SamuelThe Carter Center, Addis Ababa, Ethiopia.
Henok BirhanuThe Carter Center, Addis Ababa, Ethiopia.
Tadesse AsmareThe Carter Center, Addis Ababa, Ethiopia.
Daniel BoakyeWHO-ESPEN Lab, Ouagadougou, Burkina Faso.
Sindew M FelekeEthiopia Public Health Institute, Addis Ababa, Ethiopia.
Thomas UnnaschCollege of Public Health, University of South Florida, Tampa, Florida, United States of America.
Rory PostLondon School of Hygiene & Tropical Medicine, London, United Kingdom, United Kingdom.
Tarig HigaziDepartment of Biological Sciences, Ohio University, Zanesville, Ohio, United States of America.
Emily GriswoldHealth Programs, The Carter Center, Atlanta, Georgia, United States of America.
Charles MackenzieNTD Support Center, Task Force for Global Health, Atlanta, Georgia, United States of America.
Frank RichardsHealth Programs, The Carter Center, Atlanta, Georgia, United States of America.
The Carter Center · ETFederal Ministry of Health · SDCarter Center · USFederal Ministry of Health · ETEthiopian Public Health Institute · ETLondon School of Hygiene & Tropical Medicine · GBOhio University · USThe Task Force for Global Health · USUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnchocerciasis transmission across international borders is not uncommon, yet a coordinated cross border stops mass drug administration (MDA) decision has not been documented. METHODS/PRINCIPLE

findingsThe Galabat-Metema focus involves neighboring districts on the border between Sudan and Ethiopia. Mass drug administration (MDA) was provided once and subsequently twice per year in this focus, with twice-per-year beginning in Ethiopia's Metema subfocus in 2016 and in the Sudan's Galabat subfocus in 2008. Ov16 ELISA-based serosurveys were conducted in 6072 children under 10 years of age in the Metema subfocus in 2014, and 3931 in the Galabat in 2015. Between 2014 and 2016, a total of 27,583 vector Simulium damnosum flies from Metema and 9,148 flies from Galabat were tested by pool screen PCR for Onchocerca volvulus O-150 DNA. Only 8 children were Ov16 seropositive (all in the Metema subfocus); all were negative by skin snip PCR. The upper limit of the 95% confidence interval (UCL) for Ov16 seropositive was <0.1% for the overall focus and 0.14 positive fly heads per 2000 (UCL = 0.39/2000). However, an entomological 'hotspot' was detected on the Wudi Gemzu river in Metema district. The hotspot was confirmed when 4 more positive fly pools were found on repeat testing in 2017 (1.04 L3/2000 flies (UCL = 2.26/2000). Information exchange between the two countries led to stopping MDA in a coordinated fashion in 2018, with the exception of the hotspot at Wudi Gemzu, where MDA with ivermectin was increased to every three months to hasten interruption of transmission.

conclusionCoordinated stop MDA decisions were made by Sudan and Ethiopia based on data satisfying the World Health Organization's criteria for interruption of onchocerciasis transmission. Definitions of entomological 'hotspots' and buffer zones around the focus are proposed.

Indexed as

AnimalsChildChild, PreschoolEmigration and ImmigrationEthiopiaFemaleHumansIvermectinMaleMass Drug AdministrationOnchocerca volvulusOnchocerciasisSimuliidaeSudanIvermectin

Identifiers

PMID32027648
PMCPMC7004312
OpenAlexW3004653084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.